This competing continuation proposal for a Data Management Center (DMC) is submitted in conjunction with a parallel proposal entitled """"""""Randomized Trial of ORG 10172 in Acute or Progressing Ischemic Stroke"""""""" submitted simultaneously by Harold P. Adams, Jr., M.D. The clinical aspects of this research are documented in Dr. Adams' proposal. Briefly, a promising class of drugs called low molecular weight heparins, or heparinoids, which have selective antithrombotic effects without the anticoagulant or platelet-aggregating properties of heparin, may be effective in treating patients with acute ischemic stroke. One such heparinoid, ORG 10172, is being tested in this multi-center, randomized, double-blind, placebo- controlled trial. The primary hypothesis is that, in a population of patients with acute ischemic stroke, ORG 10172 is more efficacious than placebo in improving the likelihood of a favorable outcome (Glasgow Outcome Scale of I or II and Barthel Index of 12 or more) at three months after stroke. A total of 1300 patients will be randomly assigned to a seven-day intravenous infusion of either ORG 10172 or placebo within 24 hours of stroke onset. Patients are followed for three months post randomization, or until death. The primary reasons for extending funding are to continue patient enrollment to the target sample size, and to conduct additional statistical analyses. The Data Management Center (DMC) works closely with the Clinical Coordinating Center (CCC - Dr. Adams' group) in managing the trial, coordinating the biostatistical and data management aspects of the trial, and monitoring patient safety. The DMC is responsible for providing a variety of data management services, including receiving, tracking, editing, and correcting data collected at the 26 Participating Clinical Centers (PCCs). The DMC uses a secure, personal computer based Novell local area network for data base and file storage, printing, and remote communications services. The DMC developed a distributed data entry system for this trial, whereby data are double-key entered at the PCC and electronically transmitted to the DMC. The DMC provides the PCCs with personal computers, and trains study coordinators in using the system. The DMC provides regular reports to the PCCs regarding overdue data and data requiring correction, to the CCC regarding recruitment and payment processing, and to NIH regarding progress and safety in the trial. A group of physicians within the DMC, the In-House Safety Committee, reviews data monthly in an unblinded fashion, monitoring adverse experience trends. If the In-House Safety Committee has concerns about safety, the chair of the NIH Safety and Monitoring Committee is notified. The DMC performs all statistical analyses associated with this trial, including safety analyses and formal interim and final analyses. Investigator-initiated requests from the PCCs for analyses of baseline TOAST data are forwarded to the DMC, where analyses are performed and statistical guidance and interpretation are offered to the local investigator.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
2R01NS027960-06
Application #
2266686
Study Section
Neurological Disorders Program Project Review A Committee (NSPA)
Project Start
1990-01-01
Project End
1997-12-31
Budget Start
1995-02-13
Budget End
1995-12-31
Support Year
6
Fiscal Year
1995
Total Cost
Indirect Cost
Name
University of Iowa
Department
Public Health & Prev Medicine
Type
Schools of Medicine
DUNS #
041294109
City
Iowa City
State
IA
Country
United States
Zip Code
52242
Leira, Enrique C; Ludwig, Bryan R; Gurol, M Edip et al. (2012) The types of neurological deficits might not justify withholding treatment in patients with low total National Institutes of Health Stroke Scale scores. Stroke 43:782-6
Palesch, Yuko Y; Tilley, Barbara C; Sackett, David L et al. (2005) Applying a phase II futility study design to therapeutic stroke trials. Stroke 36:2410-4
Ringman, J M; Saver, J L; Woolson, R F et al. (2005) Hemispheric asymmetry of gaze deviation and relationship to neglect in acute stroke. Neurology 65:1661-2
Leira, Enrique C; Chang, Ku-Chou; Davis, Patricia H et al. (2004) Can we predict early recurrence in acute stroke? Cerebrovasc Dis 18:139-44
Ringman, J M; Saver, J L; Woolson, R F et al. (2004) Frequency, risk factors, anatomy, and course of unilateral neglect in an acute stroke cohort. Neurology 63:468-74
Johnston, S Claiborne; Leira, Enrique C; Hansen, Michael D et al. (2003) Early recovery after cerebral ischemia risk of subsequent neurological deterioration. Ann Neurol 54:439-44
Wilterdink, J L; Bendixen, B; Adams Jr, H P et al. (2001) Effect of prior aspirin use on stroke severity in the trial of Org 10172 in acute stroke treatment (TOAST). Stroke 32:2836-40
Bruno, A; Biller, J; Adams Jr, H P et al. (1999) Acute blood glucose level and outcome from ischemic stroke. Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators. Neurology 52:280-4
Chaturvedi, S; Adams Jr, H P; Woolson, R F (1999) Circadian variation in ischemic stroke subtypes. Stroke 30:1792-5
Adams Jr, H P; Davis, P H; Leira, E C et al. (1999) Baseline NIH Stroke Scale score strongly predicts outcome after stroke: A report of the Trial of Org 10172 in Acute Stroke Treatment (TOAST). Neurology 53:126-31

Showing the most recent 10 out of 17 publications